"Navigating the Modern News Zoo so you don't have to."
Tuesday, July 15, 2025
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.
đ Full Story
INSANE: Diddy Supporters Lather Up in Baby Oil & Twerk Outside Courthouse After Verdict đł
- How To Sell Replicas Legally In 2025? 8 Steps Guide - Robina Anwar
- The Spectator P.M. Ep. 154: New York Times Report Deepens the Autopen Scandal - Ellie Gardey Holmes
- How A Sci-Fi Masterpiece Was Shredded Into An All-Time Flop By Disney - Joshua Tyler
- Sir David Attenborough says âthe end is nearâ as he delivers devastating confession - Isaiah Amos
- SARS-CoV-2 can cause buildup of Alzheimer's-related peptides in retina
- Prince Harry Caught in Shocking Scandal That Could Tear Down the Monarchy - Isaiah Amos
United Health Stock is Crashing - But is it a Buy Now?
- 1970s Sci-Fi Shows Actually Still Worth Watching - GFR
- Post-Identity Antisemitism: The New Obsession With Israel - Ariel Harkham
- The GOPâs Audacious Midterm Strategy - David Catron
- Millionaire Migrations: Where Millionaires Are Moving Globally - Financial Samurai
- Horror Noire: A History Of Black Horror Remains A Must-See Documentary - Drew Dietsch
- The votes are in: TechCrunch Disrupt 2025 Audience Choice winners revealed for roundtables and breakouts - TechCrunch Events
